KUALA LUMPUR: The effectiveness of the Sinovac vaccine from China is similar to that of Pfizer from the United States (US) in fighting Covid-19.
Director-General of Health Tan Sri Dr Noor Hisham Abdullah said it was evidenced by medical data that showed the effectiveness of both vaccines in practical use.
“The data prove that there is not much difference between Sinovac and Pfizer vaccines in their use.
“Both are very effective in preventing severe illness and hospitalisation, yet less effective against mild or asymptomatic symptoms,” he said in a statement on Facebook today (July 20), Harian Metro reported.
Dr Noor Hisham shared a New England Journal of Medicine report published on July 7, on the use of Sinovac in Chile.
According to him, a total of 4.2 million individuals were given a complete vaccine compared to 5.5 million who were not vaccinated between February and May last year.
“Sinovac was found to reduce Covid-19 infections by 65.9 percent and hospital admissions by 87.5 percent.
“It also reduced admissions to the intensive care unit (ICU) by 90.3 per cent and reduced deaths by 86.3 per cent,” he said.
In the meantime, Dr Noor Hisham said, the Israeli Ministry of Health also showed that the Pfizer vaccine reduced Covid-19 infections by 64 percent.
He said Pfizer showed 93 percent effectiveness against severe illnesses that led to hospitalisation.